EXHIBIT 8
Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries and joint ventures as of March 31, 2023:
Name of the subsidiary/joint venture |
| Country of |
| Percentage of |
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. |
| Malaysia |
| 100%(3) |
Aurigene Oncology Limited (formerly Aurigene Discovery Technologies Limited) |
| India |
| 100% |
Aurigene Pharmaceutical Services Limited |
| India |
| 100%(3) |
beta Institut gemeinnützige GmbH |
| Germany |
| 100%(7) |
betapharm Arzneimittel GmbH |
| Germany |
| 100%(7) |
Cheminor Investments Limited |
| India |
| 100% |
Cheminor Employees Welfare Trust |
| India |
| Refer to below footnote(13) |
Chirotech Technology Limited |
| United Kingdom |
| 100%(2)(5) |
Dr. Reddy’s Research Foundation |
| India |
| Refer to below footnote(13) |
Dr. Reddy's Employees ESOS Trust |
| India |
| Refer to below footnote(13) |
Dr. Reddy’s Farmaceutica Do Brasil Ltda. |
| Brazil |
| 100% |
Dr. Reddy’s Laboratories (EU) Limited |
| United Kingdom |
| 100%(8) |
Dr. Reddy’s Laboratories (Proprietary) Limited |
| South Africa |
| 100%(8) |
Dr. Reddy’s Laboratories (UK) Limited |
| United Kingdom |
| 100%(5) |
Dr. Reddy’s Laboratories Canada, Inc. |
| Canada |
| 100%(8) |
Dr. Reddy's Laboratories Chile SPA. |
| Chile |
| 100%(8) |
Dr. Reddy’s Laboratories, Inc. |
| U.S.A. |
| 100%(8) |
Dr. Reddy’s Laboratories Japan KK |
| Japan |
| 100%(8) |
Dr. Reddy’s Laboratories Kazakhstan LLP |
| Kazakhstan |
| 100%(8) |
Dr. Reddy’s Laboratories Louisiana, LLC |
| U.S.A. |
| 100%(1) |
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd. |
| Malaysia |
| 100%(8) |
Dr. Reddy’s Laboratories New York, LLC |
| U.S.A. |
| 100%(1) |
Dr. Reddy’s Laboratories Philippines Inc. |
| Philippines |
| 100%(8) |
Dr. Reddy’s Laboratories Romania S.R.L. |
| Romania |
| 100%(8) |
Dr. Reddy’s Laboratories SA |
| Switzerland |
| 100% |
Dr. Reddy’s Laboratories Taiwan Limited |
| Taiwan |
| 100%(8) |
Dr. Reddy’s Laboratories (Thailand) Limited |
| Thailand |
| 100%(8) |
Dr. Reddy’s Laboratories LLC |
| Russia |
| 100%(8) |
Dr. Reddy’s Laboratories, LLC |
| Ukraine |
| 100%(8) |
Dr. Reddy’s New Zealand Limited |
| New Zealand |
| 100%(8) |
Dr. Reddy’s S.R.L. |
| Italy |
| 100%(9) |
Dr. Reddy’s Bio-Sciences Limited |
| India |
| 100% |
Dr. Reddy’s Laboratories (Australia) Pty. Limited |
| Australia |
| 100%(8) |
Dr. Reddy’s Laboratories S.A.S. |
| Colombia |
| 100%(8) |
Dr. Reddy’s Research and Development B.V. |
| Netherlands |
| 100%(10) |
Dr. Reddy’s Venezuela, C.A. |
| Venezuela |
| 100%(8) |
Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited (from August 19, 2020) |
| China |
| 100%(8) |
DRES Energy Private Limited |
| India |
| 26%(12) |
DRL Impex Limited |
| India |
| 100%(11) |
Dr. Reddy’s Formulations Limited (from March 11, 2021) |
| India |
| 100% |
Idea2Enterprises (India) Private Limited |
| India |
| 100% |
Imperial Credit Private Limited |
| India |
| 100% |
Industrias Quimicas Falcon de Mexico, S.A. de CV |
| Mexico |
| 100% |
Kunshan Rotam Reddy Pharmaceutical Co. Limited |
| China |
| 51.33%(4) |
Lacock Holdings Limited |
| Cyprus |
| 100%(8) |
Nimbus Health, GmbH (from February 24, 2022) |
| Germany |
| 100%(7) |
Organizational structure (continued)
Name of the subsidiary/joint venture |
| Country of |
| Percentage of |
Promius Pharma, LLC |
| U.S.A. |
| 100%(1) |
Reddy Holding GmbH |
| Germany |
| 100%(8) |
Reddy Netherlands B.V. |
| Netherlands |
| 100%(8) |
Reddy Pharma Iberia S.A.U. |
| Spain |
| 100%(8) |
Reddy Pharma Italia S.R.L. |
| Italy |
| 100%(6) |
Reddy Pharma SAS |
| France |
| 100%(8) |
SVAAS Wellness Limited |
| India |
| 100% |
(1) | Indirectly owned through Dr. Reddy’s Laboratories, Inc. |
(2) | Entity under liquidation. |
(3) | Indirectly owned through Aurigene Oncology Limited. |
(4) | Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary as per the Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements. |
(5) | Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited. |
(6) | Indirectly owned through Lacock Holdings Limited. |
(7) | Indirectly owned through Reddy Holding GmbH. |
(8) | Indirectly owned through Dr. Reddy’s Laboratories SA. |
(9) | Indirectly owned through Reddy Pharma Italia S.R.L. |
(10) | Indirectly owned through Reddy Netherlands B.V. |
(11) | Indirectly owned through Idea2Enterprises (India) Pvt. Limited. |
(12) | Accounted in accordance with IFRS 11, “Joint Arrangements”. |
(13) | The Company does not have any equity interests in this entity, but has significant influence or control over it. |